The intellectual-property provisions included in the final agreement could delay when cost-saving generic and biosimilar medicines can enter the Canadian market, writes the president of the Canadian Generic Pharmaceutical Association.
Health Minister Ginette Petitpas Taylor’s mandate in large part is focused on improving access to necessary prescription medication and reduce the cost Canadian governments pay for these drugs, writes the president of the Canadian Generic Pharmaceutical Association.
The Hill Times file photograph by Andrew Meade
Access to affordable prescription medicines is a high priority for Canadians.
People. Policy. Politics. This is an exclusive subscriber-only story.
The Federal Response to the Opioid Crisis This e-book summarizes the work on the opioid crisis that is going on at the federal level: what the House of Commons and the Senate have been listening to and acting on to help stop and mitigate this tragedy.
PIPSC president Debi Daviau says amount spent on outsourcing has increased ‘despite commitment by the government to reduce spending on external consultants to 2005 levels,’ at union’s annual general meeting.
The process of new MPs learning where their Ottawa offices will be will begin after Prime Minister Justin Trudeau announces who will be making up his re-jigged cabinet on Nov. 20, the government whip said last week.